Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Editorial
Nature Biotechnology 25, 261 (1 March 2007) | doi:10.1038/nbt0307-261
Flogging Gardasil
Abstract
In its rush to market its human papillomavirus vaccine, Merck forgot to make a strong and compelling case for compulsory immunization.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
